Prof Amin Rostami-Hodjegan PharmD, PhD, FCP, FAAPS, FJSSX

Professor of Systems Pharmacology

View graph of relations


Professor of Systems Pharmacology

Director of CAPKR


Amin is the Director of the Centre for Applied Pharmacokinetic Research (CAPKR) at the University of Manchester. In 2007, whilst working at the University of Sheffield, he became the first full Professor appointed with the title of "Systems Pharmacology". Professor Rostami has authored/co-authored over 230 highly cited articles (>11,000 citations, H-Factor >55) and in 2017 he was enlisted by ISI as one of the most highly cited researchers in the world (under the category of ‘Pharmacology & Toxicology’). Amin was a founding editor of Pharmacometrics and System Pharmacology (CPT:PSP) and has been serving on the Editorial Boards of several other clinical pharmacology and drug metabolism journals over many years. Professor Rostami is renowned for his contribution to translational modelling (e.g. PBPK) and has been an invited speaker at over 180 international and national meetings, in addition to leading numerous workshops in the area of IVIVE- PBPK linked models.

Professor Rostami has an active program of training PhD students involving proteomics, PBPK, clinical PKPD and precision dosing.  Many graduates from his team hold positions in the pharmaceutical industry or academia.

As a co-founder of Simcyp Limited (a University of Sheffield spin-off acquired by Certara) he is part-time secondee at Certara. As its Chief Scientific Officer he ensures that the latest scientific advances in the field of biosimulation are incorporated into all of the drug development efforts by various pharmaceutical companies. Certara is the largest company focused on Modellling and Simulation as well as Regulatory Strategy in the space of pharmaceutical industry.



  • 1987 - PharmD (Tabriz)

  • 1996 - PhD (Sheffield)

Memberships of committees and professional bodies


  • Co-Chair of ISoP International Advisory Board
  • Member of Host Madsen Award Committee of FIP
  • Member of the ISSX Finance Committee

Editorial Boards:

  • Acta Pharmaceutica Sciencia since 2007 (International Editorial Board)
  • Biopharm Drug Disposition (European Editor 2009 - present)
  • Clinical Pharmacology & Therapeutics: Pharmacometrics & Systems Pharmacology (Associate Editor 2012-2016)
  • Current Drug Metabolism (Co-Editor since 2015, Associate Editor for Europe 2006-2015)
  • Drug Metabolism & Pharmacokinetics (2006-present)
  • Drug Metabolism Letters (2006-2014)
  • Frontiers in Drug Metabolism and Transport (2010-present)
  • Frontiers in Toxicity Prediction (2010-present)
  • Xenobiotica (2005-2015)

Learned Societies:

Fellow of:

  • American College of Clinical Pharmacology (ACCP)
  • Clinical Section of Br Pharmacological Society (BPS)
  • Japanese Society for the Study of Xenobiotics (JSSX)
  • American Association of Pharmaceutical Sciences (ACCP)

Member of:

  • American Association of Pharmaceutical Sciences (AAPS)
  • American College of Clinical Pharmacology (ACCP)
  • American Society of Clinical Pharmacology and Therapeutics (ASCPT)
  • International Society of Pharmacometrics (ISoP) International Society for the Study of Xenobiotics (ISSX)
  • American Society for Pharmacology and Experimental Therapeutics (ASPET)

External positions

Chief Scientific Officer, Certara USA Inc

Biology, Medicine and Health (BMH) Domains

Related information


Activity: Participating in or organising event(s)Organising a conference, workshop, exhibition, performance, inquiry, course etc

Activity: External visiting positions or secondmentsVisiting an external non-academic organisation

Activity: External visiting positions or secondmentsVisiting an external non-academic organisation

View all (15)